The UK’s pharmaceutical sector remains significant, with healthy balance fostered between research-based and generic manufacturers. Government initiatives, including the £10 million funding to MHRA for patient access to new treatments, are supporting these efforts. Despite the positive growth, Brexit’s impacts on the sector, specifically on access to EU single market benefits, creates uncertainties about the future. The sector’s regulatory framework, competition laws, patent duration, and marketing authorisations are under intricate rules and legislations.
Thousands of consumer routers hacked by Russia's military
The Russian military is once again hacking home and small office routers in widespread operations that send unwitting users to sites that harvest passwords and
